Central hemodynamic effects at rest and during exercise of acute and chronic treatment with nisoldipine in essential hypertension
- PMID: 2455128
Central hemodynamic effects at rest and during exercise of acute and chronic treatment with nisoldipine in essential hypertension
Abstract
The acute and chronic hemodynamic effects of nisoldipine were studied in 19 patients (17 men, 2 women; mean age 43 years) with essential hypertension at rest supine and sitting and during steady state 100 W bicycle exercise. At rest supine, the first dose response (1 h) was reduction of intraarterial (IA) pressure (9%) and total peripheral vascular resistance (TPR; 19%) and rise in heart rate (HR; 9%) and cardiac output (CO; 12%). Thereafter, the effect leveled off: at 3 h, IA pressure, CO, and TPR were reduced 6%, 1%, and 4%, respectively. Similar results were seen at rest and during exercise. After 1 year treatment, the changes were more marked: at rest, IA pressure and TPR fell (16% and 20%, respectively) while stroke volume and CO rose slightly (4% and 6%, respectively). There was no reflex tachycardia. During 100 W exercise, IA pressure fell (14%) due to reduction both in TPR (7%) and CO (6%). Thus, at rest, nisoldipine lowers blood pressure by reduction of TPR both acutely and chronically. The initial rise in CO is lost after long-term therapy. During exercise, falls in both TPR and CO contribute to the hypotensive effect.
Similar articles
-
Nisoldipine. Central haemodynamics at rest and during exercise in essential hypertension: acute and chronic studies.J Hypertens. 1988 Feb;6(2):95-103. J Hypertens. 1988. PMID: 3351300 Clinical Trial.
-
Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.J Cardiovasc Pharmacol. 1984;6 Suppl 7:S1043-8. J Cardiovasc Pharmacol. 1984. PMID: 6085364
-
Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.Ann Clin Res. 1988;20 Suppl 48:23-30. Ann Clin Res. 1988. PMID: 3250315 Clinical Trial.
-
Age hemodynamics and exercise in essential hypertension: difference between beta-blockers and dihydropyridine calcium antagonists.J Cardiovasc Pharmacol. 1989;14 Suppl 10:S7-13. J Cardiovasc Pharmacol. 1989. PMID: 2483573 Review.
-
Essential hypertension: hemodynamic and therapeutic changes over 20 years.J Cardiovasc Pharmacol. 1991;18 Suppl 4:S1-7. J Cardiovasc Pharmacol. 1991. PMID: 1721971 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical